✦ LIBER ✦

Survival of patients with lung cancer treated with vincristine and actinomycin D. An unsuccessful trial

✍ Scribed by Jacob Bitran; Arthur Billings; Richard K. Desser; Lionel Cohen; Martin Colman; Charles Shapiro

Publisher: John Wiley and Sons
Year: 1976
Tongue: English
Weight: 255 KB
Volume: 37
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197604)37:4<1669::aid-cncr2820370409>3.0.co;2-n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined actinomycin D and vincristine i

Combined actinomycin D and vincristine in the treatment of patients with cancer

✍ Raul E. Chanes; Paul T. Condit; Richard H. Bottomley; William Nisimblat 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

A combination of actinomycin D and vincristine has been used to treat 92 patients with various kinds of cancer. The best results were obtained in patients with lung cancer, with a n initial response rate of 6096 and an average duration of remission of over 8 months. Some patients with sarcomas and m

No effect of an antiaggregant treatment

No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy results from a randomized clinical trial of 303 patients

✍ B. Lebeau; C. Chastang; J. F. Muir; J. Vincent; F. Massin; C. Fabre; Petites Cel 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

A randomized phase II trial of amonafide

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the north central cancer treatment group

✍ Dean H. Gesme Jr.; James R. Jett; Dennis D. Schreffler; John Q. Su; James A. Mai 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

Weekly docetaxel in the treatment of eld

Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma : A Minnie Pearl Cancer Research Network Phase II Trial

✍ John D. Hainsworth; Howard A. Burris III; Sharlene Litchy; Lisa H. Morrissey; Jo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Background: Weekly administration of docetaxel was found to reduce myelosuppression and other nonhematologic toxicities when compared with administration every 3 weeks. in the current phase ii trial, the authors evaluated the feasibility, toxicity, and efficacy of weekly docetaxel in the treatme

A randomized Phase II trial of echinomyc

A randomized Phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma : An Eastern Cooperative Oncology Group Study (E1587)

✍ Alex Y. Chang; KyungMann Kim; Hélène Boucher; Philip Bonomi; James A. Stewart; D 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## Background: Patients with metastatic nonsmall cell lung carcinoma (nsclc) usually have a poor prognosis. a chemotherapy regimen containing cisplatin is commonly used for symptom palliation. echinomycin is a potent bifunctional intercalator of double-strand dna; trimetrexate is a new derivative o